A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster

Pain

Volumn 142, Issue 3, 2009, Pages 209-217

  Dworkin, Robert H ^a   Barbano, Richard L ^a   Tyring, Stephen K ^b   Betts, Robert F ^a   McDermott, Michael P ^a   Pennella Vaughan, Janet ^a   Bennett, Gary J ^c   Berber, Erhan ^d   Gnann, John W ^e   Irvine, Carrie ^a   Kamp, Cornelia ^a   Kieburtz, Karl ^a   Max, Mitchell B ^f   Schmader, Kenneth E ^g  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b University of Texas Health Science Center at Houston   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d NOVARTIS PHARMA AG   (Switzerland)

^e University of Alabama at Birmingham   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute pain; Gabapentin; Herpes zoster; Oxycodone; Postherpetic neuralgia; Randomized clinical trial

Indexed keywords

FAMCICLOVIR; GABAPENTIN; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE; PARACETAMOL; PLACEBO;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DEHYDRATION; DISORIENTATION; DIZZINESS; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; POSTHERPETIC NEURALGIA; PRESYNCOPE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RASH; SEDATION; SIDE EFFECT; VOMITING;

ACUTE DISEASE; AGED; AMINES; ANALGESICS, OPIOID; CLINICAL TRIALS AS TOPIC; CYCLOHEXANECARBOXYLIC ACIDS; DELAYED-ACTION PREPARATIONS; EVIDENCE-BASED MEDICINE; FEMALE; GAMMA-AMINOBUTYRIC ACID; HERPES ZOSTER; HUMANS; MALE; NEW YORK; OXYCODONE; PAIN; PLACEBO EFFECT; TEXAS; TREATMENT OUTCOME;

EID: 61749093664     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2008.12.022     Document Type: Article

References (48)

1. Anderson K., Syrjala K.L., and Cleeland C.S. How to assess cancer pain. In: Turk D.C., and Melzack R. (Eds). Handbook of pain assessment. 2nd ed. (2001), Guilford Press, New York 579-600
2. Bajwa Z.H., and Ho C.C. Herpetic neuralgia: use of combination therapy for pain relief in acute and chronic herpes zoster. Geriatrics 56 (2001) 18-24
3. Bennett G.J. Hypotheses on the pathogenesis of herpes zoster-associated pain. Ann Neurol 35 (1994) S38-S41
4. Berry J.D., and Petersen K.L. A single dose of gabapentin reduces acute pain and allodynia inpatients with herpes zoster. Neurology 65 (2005) 444-447
5. Brentjens MH, Torres G, He J, Lee PC, Tyring SK. Reduction of postherpetic neuralgia in herpes zoster: a study of the effects of gabapentin with valacyclovir during acute zoster outbreaks. Annual meeting of the American Academy of Dermatology, San Francisco, March 2003.
6. Brisson M., Edmunds W.J., and Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 70 (2003) S31-S37
7. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127 (2001) 305-314
8. Cepeda M.S., Africano J.M., Polo R., Alcala R., and Carr D.B. What decline in pain intensity is meaningful to patients with acute pain?. Pain 105 (2003) 151-157
9. Coplan P.M., Schmader K., Nikas A., Chan I.S.F., Choo P., Levin M.J., et al. Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the Brief Pain Inventory. J Pain 5 (2004) 344-356
10. Dubinsky R.M., Kabbani H., El-Chami Z., Boutwell C., and Ali H. Practice parameter: treatment of postherpetic neuralgia: an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63 (2004) 959-965
11. Dworkin R.H., Corbin A.E., Young Jr. J.P., Sharma U., LaMoreaux L., Bockbrader H., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60 (2003) 1274-1283
12. Dworkin R.H., Johnson R.W., Breuer J., Gnann J.W., Levin M.J., Backonja M., et al. Recommendations for the management of herpes zoster. Clin Infect Dis 44 (2007) S1-26
13. Dworkin R.H., O'Connor A.B., Backonja M., Farrar J.T., Jensen T.S., Kalso E.A., et al. Pharmacologic management of neuropathic pain: evidence-based clinical recommendations. Pain 132 (2007) 237-251
14. Dworkin R.H., and Schmader K.E. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson C.P.N., and Gershon A.A. (Eds). Herpes zoster and postherpetic neuralgia. 2nd ed. (2001), Elsevier press, New York 39-64
15. Dworkin R.H., Turk D.C., Farrar J.T., Haythornthwaite J.A., Jensen M.P., Katz N.P., et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113 (2005) 9-19
16. Dworkin R.H., Turk D.C., Wyrwich K.W., Beaton D., Cleeland C.S., Farrar J.T., et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9 (2008) 105-121
17. Farrar J.T., Young J.P., LaMoreaux L., Werth J.L., and Poole R.M. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94 (2001) 149-158
18. Filadora V.A., Sist T.C., and Lema M.J. Acute herpetic neuralgia and postherpetic neuralgia in the head and neck: response to gabapentin in five cases. Reg Anesth Pain Med 24 (1999) 170-174
19. Finnerup N.B., Otto M., McQuay H.J., Jensen T.S., and Sindrup S.H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289-305
20. Garnett G.P., and Ferguson N.M. Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Rev Med Virol 6 (1996) 151-161
21. Garry E.M., Delaney A., Anderson H.A., Sirinathsinghji E.C., Clapp R.H., Martin W.J., et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs. Pain 118 (2005) 97-111
22. Gnann Jr. J.W., Crumpacker C.S., Lalezari J.P., Smith J.A., Tyring S.K., Baum K.F., et al. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients: results from a randomized, controlled clinical trial. Antimicrob Agents Chemother 42 (1998) 1139-1145
23. Gnann Jr. J.W., and Whitley R.J. Herpes zoster. N Engl J Med 347 (2002) 340-346
24. Hasnie F.S., Breuer J., Parker S., Wallace V., Blackbeard J., Lever I., et al. Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 144 (2007) 1495-1508
25. Hempenstall K., Nurmikko T.J., Johnson R.W., A'Hern R.P., and Rice A.S.C. Analgesic therapy in postherpetic neuralgia: a quantitative systematic review. PLoS Med 2 (2005) 628-644
26. Higa K., Mori M., Hirata K., Hori K., Manabe H., and Dan K. Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region most influences the duration of acute herpetic pain. Pain 69 (1997) 245-253
27. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58 (1965) 9-20
28. Hope-Simpson R.E. Postherpetic neuralgia. J R Coll Gen Pract 25 (1975) 571-575
29. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., and Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 20 (2005) 748-753
30. Jensen M.P., Chen C., and Brugger A.M. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain 4 (2003) 407-414
31. Jung B.F., Johnson R.W., Griffin D.R.J., and Dworkin R.H. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 62 (2004) 1545-1551
32. Katz J., Cooper E.M., Walther R.R., Sweeney E.W., and Dworkin R.H. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39 (2004) 342-348
33. Kuraishi Y., Takasaki I., Nojima H., Shiraki K., and Takahata H. Effects of the suppression of acute pain by gabapentin and amitriptyline on the incidence of delayed postherpetic pain in mice. Life Sci 74 (2004) 2619-2626
34. Kurtzke J.F. Neuroepidemiology. Ann Neurol 16 (1984) 265-277
35. Melzack R. The short-form McGill pain questionnaire. Pain 30 (1987) 191-197
36. Oaklander A.L. Mechanisms of pain and itch caused herpes zoster (shingles). J Pain 9 (2008) S10-S18
37. Oxman M.N., Levin M.J., Johnson G.R., Schmader K.E., Straus S.E., Gelb L.D., et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352 (2005) 2271-2284
38. Ragozzino M.W., Melton LJ I.I.I., Kurland L.T., Chu C.P., and Perry H.O. Population-based study of herpes zoster and its sequelae. Medicine 61 (1982) 310-316
39. Rice A.S.C., and Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94 (2001) 215-224
40. Rowbotham M.C., Baron R., Petersen K.L., and Fields H.L. Spectrum of pain mechanisms contributing to PHN. In: Watson C.P.N., and Gershon A.A. (Eds). Herpes zoster and postherpetic neuralgia. 2nd ed. (2001), Elsevier, New York 183-195
41. Rowbotham M.C., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
42. Russell M.L., Schopflocher P., Svenson L., and Virani S.N. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 135 (2007) 908-913
43. Schmader K.E., Sloane R., Pieper C., Coplan P.M., Nikas A., Saddier P., et al. The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 23 (2007) 490-496
44. Schuette M.C., and Hethcote H.W. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 61 (1999) 1031-1064
45. Whitley R.J., Weiss H., Gnann Jr. J.W., Tyring S., Mertz G.J., Pappas P.G., et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med 125 (1996) 376-383
46. Whitley R.J., Weiss H.L., Soong S.J., and Gnann J.W. Herpes zoster: risk categories for persistent pain. J Infect Dis 179 (1999) 9-15
47. Woolf C.J. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy. Life Sci 74 (2004) 2605-2610
48. Yih W.K., Brooks D.R., Lett S.M., Jumaan A.O., Zhang Z., Clements K.M., et al. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 5 (2005) 68